Prevalence and predictors of anti-SARS-CoV-2 serology in a highly vulnerable population of Rio de Janeiro: A population-based serosurvey

Lara E. Coelho, Paula M. Luz, Débora Castanheira, Emília M. Jalil, Hugo Perazzo, Thiago S. Torres, Sandra Wagner Cardoso, Eduardo Mesquita Peixoto, Sandro Nazer, Eduardo Massad, Mariângela Freitas da Silveira, Fernando C. Barros, Ana Tereza Ribeiro de Vasconcelos, Carlos A.m. Costa, Rodrigo T. Amâncio, Daniel Antunes Maciel Villela, Tiago Pereira, Guilherme Tegoni Goedert, Cléber Vinícius Brito dos Santos, Nádia Cristina Pinheiro Rodrigues, Beatriz Grinsztejn, Valdiléa G. Veloso, Claúdio J. StruchinerThe Lancet Regional Health - Americas 2022 · DOI

BibTeX
@inproceedings{coelho2022prevalence,
  author = {Lara E. Coelho and Paula M. Luz and Débora Castanheira and Emília M. Jalil and Hugo Perazzo and Thiago S. Torres and Sandra Wagner Cardoso and Eduardo Mesquita Peixoto and Sandro Nazer and Eduardo Massad and Mariângela Freitas da Silveira and Fernando C. Barros and Ana Tereza Ribeiro de Vasconcelos and Carlos A.M. Costa and Rodrigo T. Amâncio and Daniel Antunes Maciel Villela and Tiago Pereira and Guilherme Tegoni Goedert and Cléber Vinícius Brito dos Santos and Nádia Cristina Pinheiro Rodrigues and Beatriz Grinsztejn and Valdiléa G. Veloso and Claúdio J. Struchiner},
  title = {{Prevalence and predictors of anti-SARS-CoV-2 serology in a highly vulnerable population of Rio de Janeiro: A population-based serosurvey}},
  booktitle = {The Lancet Regional Health - Americas},
  year = {2022},
  doi = {10.1016/j.lana.2022.100338},
}

Loading related content...

Figure